Revolutionary high-end, single use, self-propelled endoscopes
Enjoy the benefits of all worlds

Consis Medical is an early-stage medical device company, devoted for the development of novel, single-use and self-propelled endoscopes. The company's first product offers the next-generation solution for colonoscopies, which until today have been uncomfortable and often painful procedures. The novel technology in the Consis colonoscopy system enables colorectal professionals to perform examinations in a much more pleasant manner, while providing the clinic with a simple and cost-effective setup.

Watch the Video
01

Need

Medical teams performing colonoscopies face a difficult trade-off between cost, quality and safety. Multi-use devices provide better diagnosis, but are costly and increase the risk of clinic-acquired infections. Single-use devices are safer and can reduce major sterilization-related expenditures, but compromise diagnosis and vision quality. Meanwhile, patients universally experience discomfort during procedures.
Need
Solution
02

Mission

To improve colonoscopy prodedures and patient outcomes by providing a safer, faster, more cost-effective solution for colonoscopies.
03

Solution

Our revolutionary semi-disposable, self-propelling colonoscopy device offers the best of all worlds: safety and cost-efficiency of a single-use device with diagnosis quality of a multi-use colonoscope.
Mission
Consis Medical

Colon Cancer

In spite of recent technological advances, conventional colonoscopy solutions
still suffer from major drawbacks.

Colorectal cancer (CRC) is the second most lethal cancer. Over 120,000 new cases are diagnosed on an annual basis in the US alone. Screening for colorectal cancer has been shown to be highly effective in the prevention and treatment of CRC. It is therefore recommended that all adults aged 50 to 75 are regularly screened for colorectal cancer.

Gastrointestinal endoscopy is one of the most widely performed medical procedures in the world, making the US and EU gastrointestinal endoscopic market to grow over $4.4 billion by 2020. By 2020, over 75 million gastrointestinal endoscopic procedures will be performed in the U.S. and Europe combined, annually. The majority of these procedures are colon cancer screenings.

However, in spite of recent technological advances, conventional colonoscopy solutions still suffer from major drawbacks.

Fear of infection is chief concern: Cleaning and sterilization procedures for colonoscopy devices are difficult and costly due to the device’s length and narrow cavities.

Recent cases of clinic-acquired infections are making the sterilization demands more stringent every year, translating into increased costs for clinics who must own several expensive devices in order to remain operational at all times while maintaining sterilization cycles. The sterilization machines and reagents are expensive, in some cases costing even more than the colonoscopes.

Colonoscopy is still considered the most expensive screening test for healthy Americans. The market needs a safer, cost-effective device that will provide quality diagnosis while reducing the related operational costs, including sedation and sterilization-related expenditure.

Disposable endoscopes are still inadequate due to the inevitable trade-off between cost and quality, and the undesired compromise on detection abilities.

Consis Medical’s new technology represents a paradigm shift that simplifies the entire operational cycle without compromising clinical quality.

Mission

To improve colonoscopy procedures and patient outcomes by providing a safer, faster, more cost-effective solution for colonoscopies.

With our semi-disposable colonoscope solution, medical teams no longer need to compromise between diagnostic quality, safety and cost-efficiency.

By making procedures faster and eliminating the need for sedation & sedation-related expenses (drugs, related insurance, additional beds & room for recovery), we make it easier for clinics to meet the increasing demand for affordable colonoscopies, and boost their ongoing revenue & profit.

At Consis Medical we believe in making colonoscopies better for everyone: clinics, medical teams and patients.

Our unique self-propelling design quickly and gently propels the inflated sleeve along the intestine. At the end of the procedure, the device head can be removed and easily sterilized while the disposable cartridge is replaced for the next patient.

Technology

Consis Medical’s game-changing modular semi disposable approach provides the optimal balance of safety, cost-effectiveness and quality diagnostic.

Its unique semi-disposable design combines an inflatable, inverted single-use sleeve with a multiple-use head, featuring high-end components for uncompromising vision quality and state-of-the art functionality.

... / ...

Device Overview

Unique semi-disposable design combines an inflatable, inverted single-use sleeve with a multiple-use head

device

1. Multi-use Head

Includes camera, light source, air/water nozzle, working channel and steering system.

2. Inflated Sleeve

Inverted inflated sleeve integrated with the multi-use head and propelled by pressurized water.

3. Connecting Harness

Connects endoscope to external control unit. The module includes: working channel port & pressurized water line

4. Disposable Sleeve Cartridge

Includes thin wall disposable sleeve packed and ready for endoscopy procedure.

Team

Team

Each of our team members unfolds the best talent within their discipline, bringing years of experience to the table.

Alexander Polischuk
Alexander has vast experience in complex technological projects. Formerly R&D team leader at Raviv Ltd (Design and production of multidisciplinary products for automotive). He holds an M.Sc. in Mechanical Engineering with a speciality in Robotics.

Alexander Polischuk

CEO

Dr. Arik Segal
Dr. Segal is an expert in Gastroenterology field.
Arik is the Head of Fecal Microbiota Transplantation (FMT) Unit in Soroka Medical Center, Be'er Sheva, Israel.

Dr. Arik Segal

CMO

Ido Agmon
Ido is experienced in evaluation, foundation and management of Life Science ventures. Formerly a strategic advisor to entrepreneurs and investors, the Fund Manager of Aviv Bio-Invest Fund and the CEO of Meytav Technology Incubator. Ido holds a B.Sc. in Life Science & Business Administration from the Tel Aviv University & MBA from the Hebrew University in Jerusalem.

Ido Agmon

Business Development

Raphael Moisa
Raphael is the Co-Founder and Managing Director of IBEX Technologies – a leading Israeli R&D firm. Raphael has over 20 years broad range of experience across variety industries, engineering management, product and technology development alongside leading innovation, entrepreneurship and global marketing management.
Raphael holds B.Sc. and M.Sc. in mechanical engineering and M.B.A. studies from Ben-Gurion University of the Negev.

Raphael Moisa

Co-Founder

Oleg Popov
Oleg is the Co-Founder and Managing Director of IBEX Technologies – a leading Israeli R&D firm. Extensive experience in production technologies while leading large professional teams.
Oleg holds M.Sc. in Mechanical Engineering.

Oleg Popov

Co-Founder

Contact Us

Mr. Ido Agmon

Business Development Manager

Have a Question?